Medical network - on February 14, the state council general office recently issued by the "on further reform and improve the use policy for producing and distributing medicines of several opinions, clearly put forward a medical representative can only be engaged in the promotion, technical advice and other activities, shall not be responsible for drug sales, broken promises recorded in the personal credit record.
After statistics show that China's medical representing about 3 million people. Opinion, means that the "face", "public relations" means or will fail, the 3 million a medical representative face unemployment or career change. According to media reports, in recent years, professional high risk and reputation is not good, plus money becomes difficult situation, a lot of medical representative "leave the nest" in succession, select thorough farewell to the pharmaceutical industry.
Once upon a time, a medical representative is considered an absolute "paid" career. But as regulators to further clarify the medicine representative professional boundaries, as well as a medical representative for the negative impact of drug prices is known by society, this profession has already stepped into recession. Need to clarify is, of course, this does not mean that a medical representative from now on will quit this occupation history. In fact, a medical representative in 2015 was included in the classification of ceremony in our country. In most countries, a medical representative is a perfectly normal job. Its role is not only "selling medicine", but to, including doctors, medical industry practitioners provide professional consultation related to the drug. This, regulators to is specification, urged the medical representative "transformation", rather than completely denying a medical representative as a normal social professional social demand.
Since the 1980 s, the concept of medical representative gradually spread to domestic, kickbacks from a large number of china-latin America relations, "medicine", and then to today hard mask, the professional medical representatives of social evolution, and the development and changes of Chinese medicine supply system have a direct link. There is still a pharmaceutical production enterprise in our country by the end of 2015, 5065, is the world's largest active pharmaceutical ingredients producer and exporter, but drug homogeneity, low level repeated problems. And it is this extensive, repetition, low-end medical supplies market, directly led to the "selling drugs" as the main responsibilities of the growth of medical representative group. Because in the face of highly homogenized drugs, drug firms to seize market, most of the time can only hope that a medical representative of lobbying, relationship and "rake-off". Plus, the drugs circulation overelaborate, also stimulated the development of the medicine representative team directly.
A large group has a medical professional ability, but free for a long time in grey area is engaged in the drugs "sell", on the one hand is a waste of talent resources, on the other hand also makes a medical representative should undertake the role of social division of labor by the profession itself has been greatly weakened. To specification, to make it back to the sun, play their positive role, is necessary. Standardize medical representative, however, can impact on the current "high price" how the intervention of the immediate effect, should still be cautious assessment.
From a medical representative may see the evolution of the profession, rather than high prices are pushing the medicine representative, as medical representative of this profession is alienation "soil" is the real "culprit". Specific see, this kind of "soil" linger for a long time in the low industry level, excessive competition, the drug supply market, handled too much drugs circulation links, as well as the medicine for the medical system and so on. Common sense is, once any a commodity circulation is overmuch, and present a low transparency, and will inevitably increase the cost of circulation, thus elevating the final market price; And reality of medicine for the medical system, means that the drug prices to include not only legitimate market premium, but also pay for the medical personnel salary, how could one not have high again? As for a medical representative "gold", can only say that part of the "high price", is far from being the key driving force.
Drug prices artificially high, neither complex enough to really difficult; A medical representative is not as simple as just by specification, will be able to "problem". In recent years, in fact, a medical representative early industry has the potential of cooling, but did not appear the corresponding price fluctuation, this in itself is the answer to a certain extent. Specification, therefore, a medical representative can have, but it can't be as a panacea for lower prices, the real push up prices of institutional factors, still should through more drastic reforms to crack.
|
